The comparator arm was placebo, a GLP-1 RA (subcutaneous administration of semaglutide 1 mg once-weekly) and basal insulin in three [18, 19, 22], one [24, 25] and two trials [20, 21], respectively, while one trial included both a placebo arm and a GLP-1 RA arm (dulaglutide 1.5 mg once-weekly) [23]
including alanine transaminase (AST), alanine transaminase (ALT) (Reitman and Frankel 1957), alkaline phosphatase (ALP) (Belfield and Goldberg 1971), as well as serum cholesterol (Deeg and Ziegenhorn 1983), triacylglycerides (TG) (Fossati and Prencipe 1982), HDL-cholesterol (Burstein et al
Regarding ethnicity and genetic background, different ethnic groups exhibit differential effectiveness of GLP-1RAs in the reduction of lung cancer risk
Assisted reproductive techniques offer excellent opportunities to infertile couples for achieving pregnancy
Monitoring During Treatment: Continuous monitoring by our trained medical staff during IV or IM administration ensures any adverse reactions are promptly addressed, and patient comfort is maintained